<p>A. CBT (upper panel) and MA (lower panel) responses to intra-MnPO injection of PaTx1 (800 nM, 0.2 µL) (black) and aCSF (0.2 µL) (red) injections in Kv4.2−/− mice B. CBT (upper panel) and MA (lower panel) responses to intra-MnPO injection of PaTx1 (800 nM, 0.2 µL) (black) and aCSF (0.2 µL) (red) injections in w-t mice. The toxin induced a ∼1 h delay in the CBT rise associated with the active phase (two-way repeated measures ANOVA followed by t-tests for each time point, * P<0.05) and did not affect motor activity (two-way repeated measures ANOVA followed by t-tests for each time point, P>0.3). A–B. The line graphs represent averages±S.D. through the 24 h recording period. Experiments were carried out in parallel in 2 groups of 6 and Kv4.2...
<p>Wheel running actograms from representative animals in the saline-injected (A), unhandled (B), an...
<p>(A) A light-dark (LD) cycle regimen used to examine the effects of a variable LD schedule on card...
<p>Icv injection of C48/80 promoted wakefulness for both (A) 0-3 hours and (B) 3-6 hours after the i...
<p>A. Intra-MnPO injection of aCSF (0.2 µL) had no effect on CBT (upper panel) or MA (lower panel) i...
<p>A. Intra-MnPO injection of H3R agonist (10 µM, 0.2 µl) induced hyperthermia (upper panel) and did...
<p>Temporal expression profiles of the circadian clock genes (<i>Per1</i>, <i>Cry1,</i> and <i>Cry2<...
Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and dev...
(A) Experiment timeline. Adult mice were randomly divided into three groups and intraperitoneally in...
Objective: Genetically hypertensive BPH/2J mice are recognized as a neurogenic model of hypertension...
Objective: Genetically hypertensive BPH/2J mice are recognized as a neurogenic model of hypertension...
<p>(A and B) Representative activity recordings of TSR mice. Actograms are double-plotted. Grey shad...
<p>A, Number and duration of NREM bouts in the last 6± SEM from each genotype (N = 6 for each group)...
<p>Wheel-running activity records double-plotted in the standard manner, with each day's activity pl...
<p>Graphs show the changes in trajectories (A) and travelled distance (B) of iNOS<sup>+/+</sup>, iNO...
<p>(A) The locomotor activity after various doses of MPH. Each mouse was placed in a locomotor activ...
<p>Wheel running actograms from representative animals in the saline-injected (A), unhandled (B), an...
<p>(A) A light-dark (LD) cycle regimen used to examine the effects of a variable LD schedule on card...
<p>Icv injection of C48/80 promoted wakefulness for both (A) 0-3 hours and (B) 3-6 hours after the i...
<p>A. Intra-MnPO injection of aCSF (0.2 µL) had no effect on CBT (upper panel) or MA (lower panel) i...
<p>A. Intra-MnPO injection of H3R agonist (10 µM, 0.2 µl) induced hyperthermia (upper panel) and did...
<p>Temporal expression profiles of the circadian clock genes (<i>Per1</i>, <i>Cry1,</i> and <i>Cry2<...
Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and dev...
(A) Experiment timeline. Adult mice were randomly divided into three groups and intraperitoneally in...
Objective: Genetically hypertensive BPH/2J mice are recognized as a neurogenic model of hypertension...
Objective: Genetically hypertensive BPH/2J mice are recognized as a neurogenic model of hypertension...
<p>(A and B) Representative activity recordings of TSR mice. Actograms are double-plotted. Grey shad...
<p>A, Number and duration of NREM bouts in the last 6± SEM from each genotype (N = 6 for each group)...
<p>Wheel-running activity records double-plotted in the standard manner, with each day's activity pl...
<p>Graphs show the changes in trajectories (A) and travelled distance (B) of iNOS<sup>+/+</sup>, iNO...
<p>(A) The locomotor activity after various doses of MPH. Each mouse was placed in a locomotor activ...
<p>Wheel running actograms from representative animals in the saline-injected (A), unhandled (B), an...
<p>(A) A light-dark (LD) cycle regimen used to examine the effects of a variable LD schedule on card...
<p>Icv injection of C48/80 promoted wakefulness for both (A) 0-3 hours and (B) 3-6 hours after the i...